BIEI Stock, Premier Biomedical Inc Information

We are a research based company that intends to discover and develop medical treatments for humans. We have a three fold corporate focus: i develop and market pain management products, ii develop our proprietary Sequential Dialysis Technique to target cancer Alzheimer s disease, ALS, blood sepsis, leukemia and other life threatening cancers, and iii develop our proprietary drug candidate Feldetrex , a potential treatment for Multiple Sclerosis, Fibromyalgia, Neuropathic Pain and Traumatic Brain Injury. Our focus recently has been on our pain management products. We are engaged in several discussions to find a suitable partner to work with us on the anti cancer drug development.